Kathryn E.
Kathryn E. Ditmer, Alexandria, VA US
Patent application number | Description | Published |
---|---|---|
20150044293 | RADIOPROTECTOR COMPOUNDS - Radioprotector compounds including 3,3′-diindolylmethane (DIM) analogs, are provided. Further provided are methods for their use in reducing or preventing radiation damage, killing a tumor cell and protecting a non-tumor cell, and treating cancer. | 02-12-2015 |
Kathryn E. Gratien, Syracuse, NY US
Patent application number | Description | Published |
---|---|---|
20110073264 | Kraft-Pulping of Hot Water Extracted Woodchips - The method of the present invention is directed towards a method to increase the pulp yield of a lignocellulosic material, or increasing pulp bulk and/or pulp viscosity. This method comprises the following steps; preparing a lignocellulosic material, contacting the lignocellulosic material in a vessel with hot water or steam for a predetermined time, producing acetic acid from the reaction of the hot water or steam and the lignocellulosic material, lowering the pH to less than about 4, removing lignocellulosic material extracts including a large percentage of hemicellulose, acetic acid and metal ions, exposing contacted lignocellulosic material to pulping chemicals in a pulping reactor, forming a contacted lignocellulosic material pulp with a kappa number below about 19 after about 90 minutes of contact with the pulping chemicals, exposing the contacted lignocellulosic material pulp to whitening agents, and producing a whitened hot water contacted lignocellulosic material pulp. | 03-31-2011 |
Kathryn E. Kasischke, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20120136346 | System and Method for Adaptive RF Ablation - A medical method, device, and system are provided, including advancing an ablation element of a medical device into contact with tissue to be treated, selecting a power level of energy to ablate the tissue, delivering energy at the selected power level to the ablation element, determining whether the ablation element is in continuous contact with the tissue, and reducing the selected power level when the ablation element ceases to be in continuous contact with the tissue. | 05-31-2012 |
20120136348 | System and Method for Adaptive RF Ablation - A medical method, device, and system are provided, including advancing an ablation element of a medical device into contact with tissue to be treated, selecting a power level of energy to ablate the tissue, delivering energy at the selected power level to the ablation element, determining whether the ablation element is in continuous contact with the tissue, and reducing the selected power level when the ablation element ceases to be in continuous contact with the tissue. | 05-31-2012 |
Kathryn E. Koprivnikar, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20080279831 | METHODS AND COMPOSITIONS FOR IDENTIFYING PROSTATE CANCER OR A HUMORAL IMMUNE RESPONSE AGAINST PROSTATE CANCER - The present invention relates to prostate cancer markers, compositions comprising such markers, immunoglobulins specific for such markers, and methods of using such markers and/or immunoglobulins to assess an immune response against prostate cancer. An immune response against the markers correlates with an immune response, in particular a humoral immune response, against prostate cancer cells which immune response is preferably associated with prophylaxis of prostate cancer, treatment of prostate cancer, and/or amelioration of at least one symptom associated with prostate cancer. | 11-13-2008 |
20100150946 | Methods and Compositions for Treating Prostate Cancer or Inducing a Humoral Immune Response Against Prostate Cancer - The present invention relates to prostate cancer markers, compositions comprising such markers, and methods of using such markers to induce or increase an immune response against prostate cancer. An immune response against the markers correlates with an immune response, in particular a humoral immune response, against prostate cancer cells which immune response is preferably associated with prophylaxis of prostate cancer, treatment of prostate cancer, and/or amelioration of at least one symptom associated with prostate cancer. | 06-17-2010 |
Kathryn E. Vanderlaag, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20110117080 | Anti-REG4 Antibodies - Antibodies to human REG4 are provided, as well as uses thereof, e.g., in treatment of proliferative disorders. Also provided is a method of screening for an antibody that inhibits REG4 bioactivity. | 05-19-2011 |